Novel peptide ligands for integrin α4β1 overexpressed in cancer cells

Masahito Mikawa, Henry Wang, Linlang Guo, Ruiwu Liu, Jan Marik, Yoshikazu Takada, Kit Lam, Derick Lau

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Using the "one-bead one-peptide" combinatorial technology, a library of random cyclic octapeptides and nonapeptides, consisting of natural and unnatural amino acids, was synthesized on polystyrene beads. This library was used to screen for peptides that promoted attachment and proliferation of bronchioloalveolar carcinoma cells (H1650), employing a "cell growth on bead" assay. Consensus peptide sequences of cNIeDXXXXc and cXNIeDXXXXc (where NIe is norleucine) were identified. With alanine scanning and site-directed deletion, a typical ligand consisted of a motif of -NIeDI/V/NIe- with two flanking cysteines. These peptide ligands were specific for promoting cell attachment of the H1650 cells and the cells of lymphoid cancers (Jurkat and Raji) but not other selected human cell lines of lung cancer and fibroblast. In an antibody blocking assay, integrin α4β1 which was overexpressed in H1650, Jurkat, and Raji, was identified as a putative receptor for these peptide ligands. Using Chinese hamster ovary cells transfected with either wild-type or mutant integrin ≤4, a critical binding site for these peptides was localized to the glycine residue at position 190 of integrin α4.

Original languageEnglish
Pages (from-to)1329-1334
Number of pages6
JournalMolecular Cancer Therapeutics
Volume3
Issue number10
Publication statusPublished - Oct 2004
Externally publishedYes

Fingerprint

Integrins
Ligands
Peptides
Neoplasms
Libraries
Norleucine
Bronchiolo-Alveolar Adenocarcinoma
Blocking Antibodies
Peptide Receptors
Polystyrenes
Consensus Sequence
Cricetulus
Alanine
Glycine
Cysteine
Ovary
Lung Neoplasms
Fibroblasts
Binding Sites
Lymphocytes

ASJC Scopus subject areas

  • Oncology
  • Drug Discovery
  • Pharmacology

Cite this

Mikawa, M., Wang, H., Guo, L., Liu, R., Marik, J., Takada, Y., ... Lau, D. (2004). Novel peptide ligands for integrin α4β1 overexpressed in cancer cells. Molecular Cancer Therapeutics, 3(10), 1329-1334.

Novel peptide ligands for integrin α4β1 overexpressed in cancer cells. / Mikawa, Masahito; Wang, Henry; Guo, Linlang; Liu, Ruiwu; Marik, Jan; Takada, Yoshikazu; Lam, Kit; Lau, Derick.

In: Molecular Cancer Therapeutics, Vol. 3, No. 10, 10.2004, p. 1329-1334.

Research output: Contribution to journalArticle

Mikawa, M, Wang, H, Guo, L, Liu, R, Marik, J, Takada, Y, Lam, K & Lau, D 2004, 'Novel peptide ligands for integrin α4β1 overexpressed in cancer cells', Molecular Cancer Therapeutics, vol. 3, no. 10, pp. 1329-1334.
Mikawa M, Wang H, Guo L, Liu R, Marik J, Takada Y et al. Novel peptide ligands for integrin α4β1 overexpressed in cancer cells. Molecular Cancer Therapeutics. 2004 Oct;3(10):1329-1334.
Mikawa, Masahito ; Wang, Henry ; Guo, Linlang ; Liu, Ruiwu ; Marik, Jan ; Takada, Yoshikazu ; Lam, Kit ; Lau, Derick. / Novel peptide ligands for integrin α4β1 overexpressed in cancer cells. In: Molecular Cancer Therapeutics. 2004 ; Vol. 3, No. 10. pp. 1329-1334.
@article{08eca2acd0b5459da772c023c08cdd1e,
title = "Novel peptide ligands for integrin α4β1 overexpressed in cancer cells",
abstract = "Using the {"}one-bead one-peptide{"} combinatorial technology, a library of random cyclic octapeptides and nonapeptides, consisting of natural and unnatural amino acids, was synthesized on polystyrene beads. This library was used to screen for peptides that promoted attachment and proliferation of bronchioloalveolar carcinoma cells (H1650), employing a {"}cell growth on bead{"} assay. Consensus peptide sequences of cNIeDXXXXc and cXNIeDXXXXc (where NIe is norleucine) were identified. With alanine scanning and site-directed deletion, a typical ligand consisted of a motif of -NIeDI/V/NIe- with two flanking cysteines. These peptide ligands were specific for promoting cell attachment of the H1650 cells and the cells of lymphoid cancers (Jurkat and Raji) but not other selected human cell lines of lung cancer and fibroblast. In an antibody blocking assay, integrin α4β1 which was overexpressed in H1650, Jurkat, and Raji, was identified as a putative receptor for these peptide ligands. Using Chinese hamster ovary cells transfected with either wild-type or mutant integrin ≤4, a critical binding site for these peptides was localized to the glycine residue at position 190 of integrin α4.",
author = "Masahito Mikawa and Henry Wang and Linlang Guo and Ruiwu Liu and Jan Marik and Yoshikazu Takada and Kit Lam and Derick Lau",
year = "2004",
month = "10",
language = "English",
volume = "3",
pages = "1329--1334",
journal = "Molecular Cancer Therapeutics",
issn = "1535-7163",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - Novel peptide ligands for integrin α4β1 overexpressed in cancer cells

AU - Mikawa, Masahito

AU - Wang, Henry

AU - Guo, Linlang

AU - Liu, Ruiwu

AU - Marik, Jan

AU - Takada, Yoshikazu

AU - Lam, Kit

AU - Lau, Derick

PY - 2004/10

Y1 - 2004/10

N2 - Using the "one-bead one-peptide" combinatorial technology, a library of random cyclic octapeptides and nonapeptides, consisting of natural and unnatural amino acids, was synthesized on polystyrene beads. This library was used to screen for peptides that promoted attachment and proliferation of bronchioloalveolar carcinoma cells (H1650), employing a "cell growth on bead" assay. Consensus peptide sequences of cNIeDXXXXc and cXNIeDXXXXc (where NIe is norleucine) were identified. With alanine scanning and site-directed deletion, a typical ligand consisted of a motif of -NIeDI/V/NIe- with two flanking cysteines. These peptide ligands were specific for promoting cell attachment of the H1650 cells and the cells of lymphoid cancers (Jurkat and Raji) but not other selected human cell lines of lung cancer and fibroblast. In an antibody blocking assay, integrin α4β1 which was overexpressed in H1650, Jurkat, and Raji, was identified as a putative receptor for these peptide ligands. Using Chinese hamster ovary cells transfected with either wild-type or mutant integrin ≤4, a critical binding site for these peptides was localized to the glycine residue at position 190 of integrin α4.

AB - Using the "one-bead one-peptide" combinatorial technology, a library of random cyclic octapeptides and nonapeptides, consisting of natural and unnatural amino acids, was synthesized on polystyrene beads. This library was used to screen for peptides that promoted attachment and proliferation of bronchioloalveolar carcinoma cells (H1650), employing a "cell growth on bead" assay. Consensus peptide sequences of cNIeDXXXXc and cXNIeDXXXXc (where NIe is norleucine) were identified. With alanine scanning and site-directed deletion, a typical ligand consisted of a motif of -NIeDI/V/NIe- with two flanking cysteines. These peptide ligands were specific for promoting cell attachment of the H1650 cells and the cells of lymphoid cancers (Jurkat and Raji) but not other selected human cell lines of lung cancer and fibroblast. In an antibody blocking assay, integrin α4β1 which was overexpressed in H1650, Jurkat, and Raji, was identified as a putative receptor for these peptide ligands. Using Chinese hamster ovary cells transfected with either wild-type or mutant integrin ≤4, a critical binding site for these peptides was localized to the glycine residue at position 190 of integrin α4.

UR - http://www.scopus.com/inward/record.url?scp=7444251748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7444251748&partnerID=8YFLogxK

M3 - Article

C2 - 15486200

AN - SCOPUS:7444251748

VL - 3

SP - 1329

EP - 1334

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

SN - 1535-7163

IS - 10

ER -